Marengo Therapeutics Announces Second Drug Candidate Nomination from Strategic Collaboration with Ipsen
Second licensed program created with Marengo's proprietary STAR precision T cell activation platform advances to IND-enabling phase
Second licensed program created with Marengo's proprietary STAR precision T cell activation platform advances to IND-enabling phase
Please help local businesses by taking an online survey to help us navigate through these unprecedented times. None of the responses will be shared or used for any other purpose except to better serve our community. The survey is at: www.pulsepoll.com $1,000 is being awarded. Everyone completing the survey will be able to enter a contest to Win as our way of saying, "Thank You" for your time. Thank You!